{
  "drug_name": "Ciprofloxacin",
  "url": "https://wikem.org/wiki/Ciprofloxacin",
  "scraped_at": "2026-01-10T03:09:11.997767",
  "sections": {
    "General": {
      "text": "Type: 2nd generation\nFluoroquinolones\nDosage Forms: IV; PO (Standard: 100, 250, 500; ER 500, 1000)\nCommon Trade Names: Cipro, Ciloxan (ophthalmic)\nGiven the multiple adverse effects listed below, there has been a recent move away from prescribing this and other fluoroquinolones as first line antibiotics for many indications (such as UTI or pneumonia).",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Fluoroquinolones",
          "url": "https://wikem.org/wiki/Fluoroquinolones"
        }
      ]
    },
    "Adult_Dosing": {
      "text": "",
      "subsections": {
        "General_2": {
          "text": "PO\n250-750mg PO q12h\nFirst Dose: 250-750mg PO x1\nIV\n200-400mg IV q12\nFirst Dose: 400mg IV x 1\nAlt: 400mg IV q8h",
          "tables": []
        },
        "UTI": {
          "text": "Uncomplicated\n500mg ER PO q24h x 3 days\nAlt: 250mg PO q12h x 3 days\nComplicated\nIV:\n400mg IV q12h x 7-14 days\nPO:\n1000mg ER PO q24h x 7-14 days\nAlt: 500mg PO q12h x 7-14 days",
          "tables": []
        },
        "Anthrax": {
          "text": "Inhalational, GI, Oropharyngeal\n400mg IV q12h OR 500mg PO q12 x 60 days\nFirst dose: 400mg IV + 1-2 additional antibiotics\nCutaneous\n400mg IV q12h OR 500mg PO q12 x 7-10 days\nInfo: Give x 60 days if\nbioterrorism\nsuspected\nPost-Exposure Prophylaxis\n500mg PO q12h x 60 days (or exposure excluded)",
          "tables": []
        },
        "Traveler's_Diarrhea[1]": {
          "text": "750mg PO BID x 1-3 days",
          "tables": []
        },
        "Typhoid_Fever": {
          "text": "500mg PO q12h x 2 weeks",
          "tables": []
        },
        "Chancroid": {
          "text": "500mg PO q12h x 3 days",
          "tables": []
        },
        "Salmonella": {
          "text": "Acute\n500-750mg PO q12h x 3-7 days\nExtend treatment x 1 week if immunocompromised\nChronic Carrier\n750mg PO q12h x 1 month",
          "tables": []
        },
        "Otitis_externa": {
          "text": "Cipro HC otic: 3 drops in affected ear BID x 7 days\nContains hydrocortisone\nNot recommended for perforation since non-sterile preparation\nCiprodex: 4 drops in affected ear BID x 7 days\nSimilar to Cipro HC but contains\ndexamethasone\nSafe with perforation\nMore expensive and not covered by many insurance companies",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "bioterrorism",
          "url": "https://wikem.org/wiki/Bioterrorism"
        },
        {
          "text": "dexamethasone",
          "url": "https://wikem.org/wiki/Dexamethasone"
        }
      ]
    },
    "Pediatric_Dosing": {
      "text": "",
      "subsections": {
        "General_3": {
          "text": "PO\n20-30mg/kg/day PO divided q12h\nFirst Dose: 10-15mg/kg PO x 1\nMax: 750mg/dose PO\nIV\n15-30mg/kg/day IV divided q8-12h\nFirst Dose: 5-15mg/kg IV x 1\nMax: 400mg/dose IV",
          "tables": []
        },
        "Anthrax_2": {
          "text": "Max (All): 400mg/dose IV or 500mg/dose PO\nInhalational, GI, Oropharyngeal\n20-30mg/kg/day IV/PO divided q12h x 60 days\nFirst Dose: 10-15mg/kg IV x 1 (give with 1-2 additional antibiotics)\nCutaneous\n20-30mg/kg/day IV/PO divided q12h x 7-10 days\nFirst Dose: 10-15mg/kg IV/PO x 1\nInfo: Give x 60 days if\nbioterrorism\nsuspected\nPost-Exposure Prophylaxis\n20-30mg/kg/day PO divided q12h x 60 days (or exposure excluded)\nFirst Dose: 10-15mg/kg PO x 1",
          "tables": []
        },
        "UTI,_Complicated_(1-17_Years_Old)": {
          "text": "Not first line given adverse effects\nIV\n6-10mg/kg IV q8h\nFirst Dose:\nMax: 400mg/dose IV\nPO\n10-20mg/kg PO q12h\nFirst Dose:\nMax: 750mg/dose PO",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "bioterrorism",
          "url": "https://wikem.org/wiki/Bioterrorism"
        }
      ]
    },
    "Special_Populations": {
      "text": "Drug ratings in pregnancy\n: C (but indicated for\nanthrax\n)\nLactation risk categories\n: Probably safe\nRenal Dosing\nAdult: renal impairment less than creatinine clearance 30 mL/min, q24hrs instead of q12hrs\nPediatric\nHepatic Dosing - no dose adjustments needed",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Drug ratings in pregnancy",
          "url": "https://wikem.org/wiki/Drug_ratings_in_pregnancy"
        },
        {
          "text": "anthrax",
          "url": "https://wikem.org/wiki/Anthrax"
        },
        {
          "text": "Lactation risk categories",
          "url": "https://wikem.org/wiki/Lactation_risk_categories"
        }
      ]
    },
    "Contraindications": {
      "text": "Allergy to class/drug\nAdministration with Tizanidine",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Adverse_Reactions": {
      "text": "",
      "subsections": {
        "Serious": {
          "text": "Prolonged QT interval and Syncope/Torsades de pointes\nPhotosensitivity\nStevens-Johnson syndrome/Toxic epidermal necrolysis\nClostridium difficile diarrhea, Pseudomembranous enterocolitis\nTendonitis or tendon rupture (black box warning) - increased risk in age >60, immunosuppressed, corticosteroid use\nperipheral neuropathy\nsevere hypoglycemia\n[2]\nmental health effects",
          "tables": []
        },
        "Common": {
          "text": "Rash\nDiarrhea\n/Nausea/Vomiting",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Diarrhea",
          "url": "https://wikem.org/wiki/Diarrhea"
        }
      ]
    },
    "Pharmacology": {
      "text": "Half-life: 4 hours\nMetabolism: Liver\nExcretion: Urine, Feces\nMechanism of Action: Bactericidal. Inhibits DNA gyrase",
      "subsections": {},
      "tables": [],
      "links": []
    }
  }
}